Reviva Pharmaceuticals (RVPH) News Today $4.40 +0.07 (+1.62%) (As of 02/9/2024 08:56 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineReviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conferencefinance.yahoo.com - January 25 at 9:53 AMRVPH Jan 2025 7.500 callca.finance.yahoo.com - January 17 at 1:31 AMReviva Pharmaceuticals: Reviva to Present at Webull LIVE! Healthcare Webinar on January 17finanznachrichten.de - January 10 at 8:20 AMReviva to Present at Webull LIVE! Healthcare Webinar on January 17finance.yahoo.com - January 10 at 8:20 AMReviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestonesfinance.yahoo.com - January 4 at 8:18 AMReviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Sees Significant Decrease in Short Interestmarketbeat.com - December 29 at 12:58 PMReviva Pharmaceuticals Stock (NASDAQ:RVPH) Dividends: History, Yield and Datesbenzinga.com - December 28 at 1:20 PMKaruna downgraded, Arm target raised: Wall Street's top analyst callsfinance.yahoo.com - December 26 at 1:07 PMReviva Pharmaceuticals (NASDAQ:RVPH) Rating Reiterated by HC Wainwrightmarketbeat.com - December 26 at 8:15 AMAnalysts Offer Insights on Healthcare Companies: Alector (ALEC), Reviva Pharmaceuticals Holdings (RVPH) and Oculis Holding (OCS)markets.businessinsider.com - December 8 at 9:58 PMReviva Pharmaceuticals to Participate in The Benchmark Company’s Upcoming Discovery One-on-One Investor Conferencefinance.yahoo.com - November 30 at 7:25 PMReviva Pharmaceuticals Holdings (RVPH) Price Target Increased by 13.48% to 17.17msn.com - November 27 at 12:56 PMReviva Pharmaceuticals: Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinanznachrichten.de - November 21 at 6:48 PMReviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - November 20 at 7:15 PMRVPH: Raise & RECOVER Results Reviewfinance.yahoo.com - November 20 at 2:15 PMReviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - November 16 at 9:30 AMReviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - November 16 at 9:30 AMReviva Pharmaceuticals: Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - November 15 at 6:53 PMReviva Reports Third Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - November 14 at 8:28 PMReviva Pharmaceuticals Holdings Inc Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 14 at 8:28 PMReviva Pharmaceuticals: Positive Results In Phase 3 But The Stock Is Back Where It Startedmsn.com - November 2 at 9:49 AMReviva Pharmaceuticals Holdings Inc Ordinary Sharesmorningstar.com - November 1 at 11:46 PMRVPH: RECOVER Toplinefinance.yahoo.com - November 1 at 1:45 PMHC Wainwright & Co. Maintains Reviva Pharmaceuticals Holdings (RVPH) Buy Recommendationmsn.com - October 31 at 7:29 PMRoth MKM Reiterates Reviva Pharmaceuticals Holdings (RVPH) Buy Recommendationmsn.com - October 31 at 7:29 PMREVIVA PHARMACEUTICALS, INC.reuters.com - October 30 at 1:23 PMCould This Be A Breakthrough in Mental Health? Reviva's Schizophrenia Drug Shows Promising Results In Key Trialbenzinga.com - October 30 at 1:23 PMReviva posts late-stage data for schizophrenia candidatemsn.com - October 30 at 1:23 PMmarketbeat.com - October 30 at 12:21 PMmarketbeat.com - October 30 at 12:13 PMmarketbeat.com - October 30 at 9:34 AMReviva Pharma Sees Positive Results in Trial for Schizophrenia Treatmentmarketwatch.com - October 30 at 8:23 AMReviva Pharma's schizophrenia drug succeeds in late-stage studyreuters.com - October 30 at 8:23 AMSchizophrenia drug developer eyes late-stage clinical trial data this monthbizjournals.com - October 13 at 7:12 PMSharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report on Bloomberg TVfinanznachrichten.de - September 29 at 9:27 AMSharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TVfinance.yahoo.com - September 29 at 9:27 AMReviva Pharmaceuticals: A Binary Event Approaches With Results From RECOVERmsn.com - September 27 at 9:10 AMReviva Pharmaceuticals Holdings: A Promising Investment Based on Successful Brilaroxazine Schizophrenia Studiesmarkets.businessinsider.com - September 26 at 7:06 PMReviva Announces Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophreniafinance.yahoo.com - September 25 at 7:33 AMReviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report on Bloomberg TVfinanznachrichten.de - September 22 at 5:36 PMReviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TVfinance.yahoo.com - September 22 at 5:36 PMReviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Average Rating of "Buy" from Analystsmarketbeat.com - September 22 at 8:12 AMReviva Pharmaceuticals (NASDAQ:RVPH) Given "Buy" Rating at Roth Capitalmarketbeat.com - September 22 at 6:49 AMRoth MKM Initiates Coverage of Reviva Pharmaceuticals Holdings (RVPH) with Buy Recommendationmsn.com - September 20 at 12:58 PMReviva Pharmaceuticals Holdings (RVPH) Receives a New Rating from Roth MKMmarkets.businessinsider.com - September 20 at 7:57 AMReviva to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 8:25 AMRVPH: RECOVER Enrollment Completefinance.yahoo.com - August 18 at 5:02 PMReviva Announces Enrollment Completion for Pivotal Phase 3 RECOVER Study for Brilaroxazine in Schizophreniafinance.yahoo.com - August 17 at 7:53 AMWe're A Little Worried About Reviva Pharmaceuticals Holdings' (NASDAQ:RVPH) Cash Burn Ratefinance.yahoo.com - August 16 at 9:12 AMReviva Reports Second Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - August 14 at 4:55 PM Get Reviva Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVPH and its competitors with MarketBeat's FREE daily newsletter. Email Address RVPH Media Mentions By Week RVPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVPH News Sentiment▼1.870.92▲Average Medical News Sentiment RVPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVPH Articles This Week▼11▲RVPH Articles Average Week Get Reviva Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PMVP News VAXX News CLSD News LPTX News NERV News CELU News TRVI News PRPH News CARM News AFMD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVPH) was last updated on 2/12/2024 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.